0,名称,半衰期实验值,分类标签,预测标签
c1(nc(cc2ccccc12)C(=O)N([C@@H](CC)C)C)c1c(cccc1)Cl,PK11195,3.7,1,
c1cc(nc(c1)C(=O)O)Cc2cc(ccc2OCc3ccc(cc3F)Cl)Cl,GSK269984A,8.15,1,
[H]N(c1c(c(nc(c2ccnc(c2)c2nnnn2[H])n1)OCCO[H])Oc1ccccc1OC)S(c1ccc(C)cn1)(=O)=O,Clazosentan,2.6,0,
C(CCNCCN1C(=O)c2c(ccc3ccccc23)C1=O)NCCN1C(=O)c2c(ccc3ccccc23)C1=O,Elinafide,52.6,1,
C(OP(=O)(NCCBr)NCCBr)c1n(C)c(nc1)N(=O)=O,TH-302,1,0,
NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,Kanamycin,2.1,0,
C1[C@H](N(CS1)C([C@@H]1CCC(N1)=O)=O)C(O)=O,Pidotimod,3.8,1,
c1([n+](cccc1)C)\C=N\O,Pralidoxime,1.4,0,
CS(=O)(=O)c1ccc2c(c1)N(c3ccccc3S2)CCCN4CCC(CC4)C(=O)N,Metopimazine,4,1,
C[C@]12CC[C@H]3[C@@H](CCc4cc(OS(=O)(=O)O)ccc34)[C@@H]1CC[C@@]2(O)C#C,Ethinylestradiol-3-Sulfate,8.4,1,
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(=O)O)\c3csc(N)n3,Ceftizoxime,1.5,0,
CCN(CC)Cc1cc(ccc1O)Nc2ccnc3c2ccc(c3)Cl,Amodiaquine,2.1,0,
[H]N([H])[C@@H]1[C@@H]([C@@H](O[C@@H]2C[C@H]3[C@H](C(=O)O[H])[C@H](C[C@@](C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@@H](C)[C@H](C)[C@@H]([C@@H](C)C=CC=CC=CC=CC=CC=CC=C2)O[H])O[H])O[H])O[H])O[H])O[H])(O[H])O3)O[H])O[C@H](C)[C@H]1O[H])O[H],Amphotericin B,40,1,
c1(c(ccc(c1)S(C)(=O)=O)OC)C(NCCN(CC)CC)=O,Tiapride,3.2,1,
O[C@@H]1C[C@@](C[C@@H](OC(=O)\C=C\c2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)\C=C\c3ccc(O)c(O)c3)C(=O)O,"1,3-DCQA",1.37,0,
c1(OC(N(CCCCCCN(C(Oc2c[n+](ccc2)C)=O)C)C)=O)c[n+](ccc1)C,Distigmine,59.8,1,
CC(=O)Nc1c(I)c(NC(=O)C)c(I)c(C(=O)O)c1I,Diatrizoic Acid (Amidotrizoate),1.8,0,
CC#CCC(C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(=C/CCCC(=O)O)\C[C@H]12,Iloprost,0.57,0,
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1,Vinblastine,67,1,
CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@H](Cc2ccccc2)C(=O)O,Nateglinide,1.5,0,
CN(C)CCCN1c2ccccc2CCc3ccccc13,Imipramine,16,1,
CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1OC(=O)C(C)(CO)CO,Temsirolimus,18,1,
C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4)O[C@@H]3C)O[C@@H]2C,Digoxin,38,1,
Cc1onc(c2ccccc2)c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O,Oxacillin,0.7,0,
Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O,Naltrexone,1.9,0,
N1(c2ccccc2)N=C(C)CC1=O,Edaravone,2.36,0,
B1([C@H](CC[C@H](O1)CC(=O)O)NC(=O)Cc2cccs2)O,Vaborbactam,1.34,0,
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,Azithromycin,69,1,
c1ccc(cc1)n2cc(cc(c2=O)c3ccccc3C#N)c4ccccn4,Perampanel,183,1,
COc1cc2c(N)nc(nc2c(OC)c1OC)N3CCN(CC3)C(=O)OCC(C)(C)O,Trimazosin,3.1,1,
CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3c[nH]c4c3cccc4)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc5c[nH]c6c5cccc6)C(=O)N[C@@H](Cc7ccccc7)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc8cnc[nH]8)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc9ccc(cc9)O)NC(=O)C,Enfuvirtide,4,1,
C(c1ccco1)(=O)O[C@]1([C@@]2([C@H]([C@@H]3[C@]([C@@]4(C(=CC(=O)C=C4)CC3)C)(Cl)[C@H](C2)O)C[C@H]1C)C)C(CCl)=O,Mometasone Furoate,4.4,1,
CC1Nc2cc(Cl)c(cc2C(=O)N1c3ccccc3C)S(=O)(=O)N,Metolazone,20,1,
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)C)\c3csc(N)n3,Cefotaxime,1.2,0,
c1c(c(cc(c1Cl)N)OCC2CC2)C(=O)NC3CN4CCC3CC4,Pancopride,13.5,1,
CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(CNCC(C)(C)C)c(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C,Omadacycline,15,1,
C(C(=O)N[C@H]1[C@H](Oc2c3cc4[C@H](C(N[C@@H]5c6cc(c7c([C@@H](NC([C@H]([C@@H](c8cc(c(O3)cc8)Cl)O[C@H]3[C@@H]([C@H]([C@H](O)[C@H](O3)CO)O)NC(C)=O)NC5=O)=O)C(=O)O)cc(O)cc7O[C@H]3O[C@@H]([C@@H](O)[C@@H]([C@@H]3O)O)CO)c(cc6)O)=O)NC([C@@H]3c5cc(Oc6cc(ccc6O)[C@@H](C(N[C@@H](C(N3)=O)Cc3cc(c(Oc2c4)cc3)Cl)=O)N)cc(c5)O)=O)O[C@@H]([C@H](O)[C@@H]1O)CO)C\C=C/CCCCC,Teicoplanin A2-1,48.1,1,
COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC,Trimetrexate,17,1,
c1(c(c(c(I)c(c1I)C(N[C@@H]([C@@H](CO)O)CO)=O)C(N[C@@H]([C@@H](CO)O)CO)=O)I)N(C(CC(N(c1c(c(c(I)c(c1I)C(N[C@@H]([C@@H](CO)O)CO)=O)C(N[C@@H]([C@@H](CO)O)CO)=O)I)C)=O)=O)C,Iotrolan,2.03,0,
CCC1=C[C@@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC,Vinorelbine,26,1,
CCc1c2cc(ccc2nc-3c1Cn4c3cc5c(c4=O)COC(=O)[C@@]5(CC)O)OC(=O)CCC(=O)Oc6c(c(c7c(c6C)CC[C@@](O7)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)C,Tenifatecan,3.77,1,
CN1[C@@H]2CCC[C@H]1C[C@H](C2)NC(=O)c3nn(C)c4ccccc34,Granisetron,5.2,1,
c1c(OC[C@@H](CNCc2cc(c(OC)cc2)OC)O)cc2c(c1)[nH]c(cc2)=O,Toborinone,3.3,1,
C1(=O)N2[C@@H]([C@H]1[C@H](O)C)SC(COC(N)=O)=C2C(=O)[O-].[Na+],Ritipenem ,0.54,0,
N12[C@@H]([C@@H](NC(\C(c3csc(n3)N)=N/OC)=O)C2=O)SCC(=C1C(O)=O)CSc1n(nnn1)C,Cefmenoxime,0.89,0,
CCCCCNC(=N)N\N=C\c1c[nH]c2ccc(OC)cc12,Tegaserod,11,1,
CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C,Beclomethasone dipropionate,0.5,0,
C1O[C@]1(C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(=O)CN1CCOCC1)CCc1ccccc1)=O)CC(C)C)=O)Cc1ccccc1)=O)CC(C)C)=O)C,Carfilzomib,1.1,0,
NC1=CC(=CNC1=O)c2ccncc2,Amrinone,2,0,
c1cc(ccc1C(=O)O)NC(=O)NCCN2CCN=C2c3ccncc3,CGP15720A,4.9,1,
N12[C@@H]([C@@H](NC([C@@H](c3ccccc3)O)=O)C2=O)SCC(=C1C(O)=O)CSc1n(nnn1)CS(O)(=O)=O,Cefonicid,5.1,1,
c1cc(cc[n+]1CC1=C(N2C([C@H]([C@H]2SC1)NC(=O)\C(=N\OC)c1nc(sc1)N)=O)C(=O)[O-])c1cnco1,DQ-2556,1.78,0,
CC1=CC=C(SC2=C(C=CC=C2)N2CCNCC2)C(C)=C1,Vortioxetine,72,1,
c12c(C[C@H](CC2)NCCC)sc(n1)N,Pramipexole,12.4,1,
C\C=C\C1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O,Cefprozil,1.2,0,
n1(nnnc1SCC1=C(N2[C@H](OC1)[C@@](C2=O)(OC)NC(=O)CSC(F)F)C(O)=O)CCO,Flomoxef,0.6,0,
COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24,Galanthamine,5.3,1,
CS(=O)(=O)[N@@](N(S(=O)(=O)C)C(=O)NC)CCCl,Laromustine,0.49,0,
Cc1cc(ccc1[C@H]2CNCCN2C(=O)N(C)[C@H](C)c3cc(cc(c3)C(F)(F)F)C(F)(F)F)F,Vestipitant,10.03,1,
NC(=N)Nc1nc(CSCCC(=N)NS(=O)(=O)N)cs1,Famotidine,2.8,0,
COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,Oxycodone,5.5,1,
COc3cccc(c13)c(C(=O)N(CC2C)CCN2C)cn1CC4CCCCC4,Org 28611,4.2,1,
CCC(=O)O[C@@](Cc1ccccc1)([C@H](C)CN(C)C)c2ccccc2,Propoxyphene,18,1,
CCCC(=O)N1CCCN(CC1)c2nc(N)c3cc(OC)c(OC)cc3n2,Bunazosin,2,0,
c1(cc(c(c(c1)OC)OC)OC)/C=C\c1ccc(c(c1)OP(=O)(O)O)OC,Combretastatin A4 Phosphate,0.47,0,
CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,Carbenicillin,1.1,0,
[H]OC(COc1cccc2C[C@H]3[C@H](CC[C@@H](CCCCC)O[H])[C@H](C[C@H]3Cc12)O[H])=O,Treprostinil,0.82,0,
C1(C(=C([C@@](C(=C1C(\C=C\c1ccc(cc1)O)=O)O)(O)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)O)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)=O,Hydroxysafflor yellow A,2.9,0,
CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2Oc5c(O)ccc(C[C@@H]14)c35,Hydromorphone,2.3,0,
c1c2c(c(c(c1F)N3CC(C3)O)Cl)n(cc(c2=O)C(=O)O)c4c(cc(c(n4)N)F)F,Delafloxacin,2.1,0,
OC(=O)C1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,Chlorazepate,2.4,0,
[H]N([H])[C@H]1C[C@H](O[C@H]2C[C@@](Cc3c2c(c2C(c4c(cccc4OC)C(c2c3O[H])=O)=O)O[H])(C(CO[H])=O)O[H])O[C@@H](C)[C@H]1I,Iododoxorubicin,10.3,1,
C[C@@H](C(=O)N)NCc1ccc(cc1)OCc2cccc(c2)F,Safinamide,21.67,1,
C(Nc1c(cc(NCc2ccc(F)cc2)cc1)N)(=O)OCC,Ezogabine,9,1,
C1CC[C@@H]2C[C@H](N([C@@H]2C1)C([C@H](C)N[C@@H](CCc1ccccc1)C(OCC)=O)=O)C(=O)O,Trandolapril,0.26,0,
CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O,Oxytetracycline,10,1,
CC(Cc1ccc(O)cc1)NCC(O)c2cc(O)cc(O)c2,Fenoterol,0.87,0,
C=C(C[C@@H](C(=O)O)NC(=O)C1=CC=C(C=C1)CCC2=CN=C3C(=N2)C(=NC(=N3)N)N)C(=O)O,MDAM,8.2,1,
NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)C(Cc3c[nH]c4ccccc34)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O)C(=O)N,Eptifibatide,4.2,1,
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,Ampicillin,1.4,0,
C12CC3C(C1)(CC(C3)C2)c1nc2n(c(=O)n(c(=O)c2[nH]1)CCC)CCC,Rolofylline,18.1,1,
CC(CCc1ccc2OCOc2c1)NCC(O)c3ccc(O)c(c3)C(=O)N,Medroxalol,11,1,
Cc1ccc(cc1C(c2c(cc(cc2C)C(=O)O)C)O)n3ccnc3,Y 20811,2.37,0,
CCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,Propionyl-L-carnitine,1.28,0,
C1C(=Cc2c(O1)cc(cc2)O)c1ccc(cc1)O,Phenoxodiol,0.67,0,
CC(Cn1cnc2c1c(=O)n(c(=O)n2C)C)O,Proxyphyllin,7.8,1,
CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13,Clomipramine,26,1,
Clc1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,Delorazepam (Chlordesmethyldiazepam),200,1,
c12c(c(c(C(O)=O)cn1NC)=O)cc(F)c(c2)N1CCN(C)CC1,Amifloxacin,4.66,1,
CCN1C=C(C(=O)O)C(=O)c2cc(F)c(nc12)N3CCNCC3,Enoxacin,5.1,1,
C[C@H]([C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2cnc[nH]2)N)O,Secretin (human),2.41,0,
C[C@@H](c1ncncc1F)[C@](O)(Cn2cncn2)c3ccc(F)cc3F,Voriconazole,5.6,1,
CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13,Quinacrine,120,1,
C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CS[C@@H]4CC[C@@H](N)C[C@H]4O,Lefamulin,6.4,1,
CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc3c4Oc5ccc(cc5Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@H]6C(=O)N[C@H]7C(=O)N[C@@H]([C@H](O)c8ccc(Oc3cc6c4)c(Cl)c8)C(=O)N[C@H](C(=O)O)c9cc(O)c(CNCP(=O)(O)O)c(O)c9c%10cc7ccc%10O)O[C@@H](C)[C@H]1O,Telavancin,6.7,1,
c1(c(cccc1)OC[C@@H](CNC(C)C)O)OCC=C,Oxprenolol,1.09,0,
C1OCCN(c2ccc(cc2)N2C(O[C@H](C2)CNC(c2sc(cc2)Cl)=O)=O)C1=O,Rivaroxaban,7,1,
CO[C@]1(NC(=O)Cc2cccs2)[C@H]3SCC(=C(N3C1=O)C(=O)O)COC(=O)N,Cefoxitin,0.81,0,
n1([C@H]2[C@@H]([C@@H](O)[C@@H]([C@H](O2)CO)OC)O)c2c3c(c4C(=O)N(C(c4c2c2c1c(Cl)ccc2)=O)CCN(CC)CC)c1cccc(c1[nH]3)Cl,Becatecarin,48.9,1,
OC(Cc1cccnc1)(P(=O)(O)O)P(=O)(O)O,Risedronic acid (Risedronate),200,1,
COc1ccc2[nH]c(nc2c1)S(=O)Cc3ncc(C)c(OC)c3C,Omeprazole,0.58,0,
N[C@@H]1[C@@H]([C@@H](O[C@H](O[C@@H]2c3c(O)c4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C[C@@](C2)(O)C(CO)=O)C1)C)O[C@@H]1CCCCO1,Pirarubicin,11.1,1,
[H]OC1=C(C(=O)Oc2ccccc12)[C@H](CC(C)=O)c1ccc(cc1)[N+]([O-])=O,Acenocoumarol,7.22,1,
C(C(C)C)CCCCCCC(=O)N[C@H]1[C@H](Oc2c3cc4[C@H](C(N[C@@H]5c6cc(c7c([C@@H](NC([C@H]([C@@H](c8cc(c(O3)cc8)Cl)O[C@H]3[C@@H]([C@H]([C@H](O)[C@H](O3)CO)O)NC(C)=O)NC5=O)=O)C(=O)O)cc(O)cc7O[C@H]3O[C@@H]([C@@H](O)[C@@H]([C@@H]3O)O)CO)c(cc6)O)=O)NC([C@@H]3c5cc(Oc6cc(ccc6O)[C@@H](C(N[C@@H](C(N3)=O)Cc3cc(c(Oc2c4)cc3)Cl)=O)N)cc(c5)O)=O)O[C@@H]([C@H](O)[C@@H]1O)CO,Teicoplanin A2-5,66.8,1,
c1(ccccc1)C[C@H](C)N,Amphetamine (-d),7.3,1,
N12C(=O)N([C@H](CC[C@H]1C(=O)N)C2)OS(=O)(=O)O,Avibactam,1.7,0,
CN(C)C(=O)CCS[C@H](SCCC(=O)O)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1,Verlukast,2.3,0,
N(c1c(cccc1Cl)Cl)(C=1NCCN1)CC=C,Alinidine,3.14,1,
COc1ccc(cc1)[C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(=O)C,Diltiazem,5.6,1,
CN[C@@H]1C[C@H]2OC(C)([C@@H]1OC)n3c4ccccc4c5c6[C@@H](O)NC(=O)c6c7c8ccccc8n2c7c35,"Hydroxystaurosporine, 7-",790,1,
CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3,Rosiglitazone,3.9,1,
c1c(sc(N(Cc2cc3c(cc2)[nH]c(nc3=O)C)C)c1)C(=O)N[C@@H](CCC(O)=O)C(=O)O,Raltitrexed,140,1,
C[C@@H]1C(=O)O[C@H]2C[C@@]34[C@H]5C[C@@H](C(C)(C)C)C36[C@@H](OC(=O)[C@@H]6O)OC4(C(=O)O5)[C@@]12O,Ginkgolide A,3.8,1,
[H]OC(CCCCON=C(c1cccc(c1)C(F)(F)F)c1cccnc1)=O,Ridogrel,7.54,1,
COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,Epirubicin,36,1,
c12c3c(OC(c1ccc(c2)C)(C)C)cc(CCCCC)cc3O,Cannabinol,25.51,1,
c1(c2c(nc(N3CCN(C)CC3)nc2)N)c(c(cc(c1)Cl)Cl)Cl,Sipatrigine,10.98,1,
c12c(c(c(C(O)=O)cn1CC)=O)cnc(n2)N1CCNCC1,Pipemidic acid,3.69,1,
O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)ON(=O)=O,Isosorbide-5-Mononitrate,4.1,1,
Cc1c(c2ccccc2[nH]1)CCNCc3ccc(cc3)/C=C/C(=O)NO,Panobinostat,13.1,1,
Clc1cccc(Cl)c1NC2=NCCN2,Clonidine,7.6,1,
n1(c(cnc1C)[N+](=O)[O-])C[C@@H](CCl)O,,12,1,
N[C@@H](CCC(=O)O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H]1C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N2[C@H](C(N[C@@H]3C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N4[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H]5C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CC(=O)O)=O)CCCNC(N)=N)=O)[C@@H](O)C)=O)CSSC1)=O)CCSC)=O)CCCCN)=O)CCCCN)=O)CSSC5)=O)CCC(=O)O)=O)CCC(=O)O)=O)CC(C)C)=O)CO)=O)CCC(=O)O)=O)Cc1ccccc1)=O)CCCNC(N)=N)=O)CC(=O)N)=O)CCC(=O)N)=O)CC(=O)N)=O)=O)CCC(=O)O)=O)CSSC3)=O)=O)=O)Cc1ccc(cc1)O)=O)[C@@H](C)CC)=O)Cc1ccccc1)=O)CCC(=O)O)=O)CCC(=O)O)=O)=O)CCC(=O)N)=O)CCCNC(N)=N)=O)[C@@H](O)C)=O)Cc1ccccc1)=O)[C@@H](C)CC)=O)CC(=O)N)=O)Cc1ccccc1)=O)Cc1ccccc1)=O)Cc1c[nH]c3c1cccc3)=O)CCCNC(N)=N)=O)CCC4)=O)Cc1[nH]cnc1)=O)C)=O)C)=O)CCCNC(N)=N)=O)=O)CCC2)=O)=O)CC(=O)O)=O)CC(=O)O)=O)C)=O)CCCCN)=O)Cc1ccccc1)=O)C)=O)=O)Cc1ccccc1)=O)CO)=O)Cc1[nH]cnc1)=O)CCSC)=O)C)=O,Ecallantide,1.8,0,
[nH]1cncc1C1(Cc2c(C1)cccc2)CC,Atipamizole,1.7,0,
CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(=O)O)\C(=O)O,Cilastatin,0.86,0,
Clc1ccc2N(C3CCN(CCCN4C(=O)Nc5ccccc45)CC3)C(=O)Nc2c1,Domperidone,7.5,1,
C1([C@H]2[C@@]([C@@]3(C([C@H]4[C@@](CC[C@@](C4)(C(O)=O)C)(C)CC3)=C1)C)(CC[C@@H]1[C@@]2(CC[C@@H](C1(C)C)O[C@@H]1[C@H](O[C@@H]2O[C@@H]([C@@H](O)[C@@H]([C@H]2O)O)C(O)=O)[C@H]([C@H](O)[C@H](O1)C(O)=O)O)C)C)=O,Glycyrrhizin,8.83,1,
S(c1ccc(C(=O)CCC(=O)O)cc1)(=O)(=O)CCCOc1c(c(O)c(cc1)C(=O)C)CCC,L-648051,0.04,0,
CC(C)NCC(c1cc(cc(c1)O)O)O,Metaproterenol,6.41,1,
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,Thalidomide,4.7,1,
CN(C)CC\C=C/1\c2ccccc2Sc3ccc(Cl)cc13,Chlorprothixene,25.8,1,
NC(=N)c1ccc(CNC(=O)[C@@H]2CCN2C(=O)[C@H](NCC(=O)O)C3CCCCC3)cc1,Melagatran,1.6,0,
CCCCc1ncc(\C=C(/Cc2cccs2)\C(=O)O)n1Cc3ccc(cc3)C(=O)O,Eprosartan,2.1,0,
C(O)[C@@]12[C@H](C3=CC[C@H]4[C@@]([C@@]3(C[C@H]2O)C)(C)CC[C@@H]2[C@]4(C)CC[C@@H]([C@@]2(CO)C)O[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O)[C@@H](O)[C@@H]([C@H](O2)C(=O)O)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)CC([C@H]([C@@H]1OC(=O)C)OC(=O)/C(=C\C)/C)(C)C,Escin Ib,1.8,0,
COc1ccsc1CNCC[C@]2(CCOC3(C2)CCCC3)c4ccccn4,Oliceridine,1.8,0,
C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=C(F)C(=O)NC2=O,Doxifluridine,0.35,0,
C(=O)(c1cc(c(cc1)Nc1nc2c(cn1)N(C(=O)[C@H](N2C(C)C)CC)C)OC)N[C@H]1CC[C@@H](CC1)N1CCN(CC1)CC1CC1,Volasertib,113,1,
C(Oc1ccccc1)(Oc1ccccc1)CN(C)C,Medifoxamine,4.4,1,
COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1c2ncc([nH]2)c3ccc(cc3)c4ccc(cc4)c5cnc([nH]5)[C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C,Daclatasvir,13.5,1,
c12c(c(c(C\C=C(\CCC(O)=O)C)c(c1C)OC)O)C(=O)OC2,Mycophenolic acid,9.7,1,
c1ccccc1CC[C@H](N[C@@H](C(N1[C@@H](CC2(C1)SCCS2)C(=O)O)=O)C)C(=O)OCC,Spirapril,8.6,1,
c1(=C\c2c([nH]cn2)C(C)(C)C)\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O,Plinabulin,6.3,1,
Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,Suramin,1200,1,
CS(=O)(=O)c1cc(cc2c1n(c3c2CC[C@@H]3CC(=O)O)Cc4ccc(cc4)Cl)F,Laropiprant,11.8,1,
CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5nnn[nH]5,Irbesartan,14,1,
CC[C@@]1(c2cc-3n(c(=O)c2COC1=O)Cc4c3nc5cc6c(cc5c4CN7CCN(CC7)C)OCCO6)O,Lurtotecan,3.54,1,
COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I,Iopromide,2.6,0,
COc1cccc(OC)c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O,Methicillin,0.64,0,
Oc1ccc(cc1)/C=C/C(=O)CCN(C)CCc2ccc3OCOc3c2,Piperphentonamine,0.1,0,
CC(C)N(CC[C@H](c1ccccc1)c2cc(C)ccc2O)C(C)C,Tolterodine,2.4,0,
CCC[C@H]1CN([C@@H](CC)C(=O)N)C(=O)C1,Brivaracetam,8.98,1,
NC1=NC(=O)C2=C(NCC(CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N2C=O)N1,Folinic acid,1.3,0,
NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F,Hydroflumethiazide,5.2,1,
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(OS(=O)(=O)O)C#C,Ethinylestradiol-17-Sulfate,9.3,1,
CN1CC(c2ccccc2)c3cccc(N)c3C1,Nomifensine,6.5,1,
CC(C(=O)O)Oc1ccc(cc1)Oc2cnc3ccc(cc3n2)Cl,XK469R,48.2,1,
CN1CCN(CC1)CC(=O)N(C)c2ccc(cc2)N/C(=C\3/c4ccc(cc4NC3=O)C(=O)OC)/c5ccccc5,Nintedanib,9.5,1,
CCOC(=O)C1(CCN(C)CC1)c2ccccc2,Meperidine,7.9,1,
C=CC(=O)N1CCCC(C1)[n@]2c3c(c(n2)c4ccc(cc4)Oc5ccccc5)c(ncn3)N,Ibrutinib,5,1,
CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)\[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\C(=C/[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)\C)OC)[C@H](C[C@H]4C)OC,Tacrolimus,26,1,
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,Estradiol,1.7,0,
CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc3ccncc3)C2=O)C(=O)O,Cephapirin,1.2,0,
O=c1n(c2c([nH]1)nccc2)C1CCN(CC1)C(=O)N[C@H]1C(=O)N(CC(F)(F)F)C[C@@H](CC1)c1c(F)c(F)ccc1,Telcagepant,8.2,1,
Cc1cccc(c1)N2CC(CO)OC2=O,Toloxatone,1.6,0,
c1ccc(cc1)C2(C(=O)NC(=O)N2)c3ccccc3,Phenytoin,16.8,1,
COc1cc(CC2c3c(CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]4(C)CCc5cc(OC)c(OC)c(OC)c5C4Cc6cc(OC)c(OC)c(OC)c6)cc(OC)c(OC)c3OC)cc(OC)c1OC,Doxacurium,1.7,0,
C=1(c2c(cccc2)CC1CCN(C)C)[C@@H](c1ccccn1)C,Dimetindene,4.6,1,
c1(cc(c(O)cc1)O)CCN,Dopamine,0.42,0,
C(O)CCN1c2c(cc(C[C@H](NCCOc3c(cccc3)OCC(F)(F)F)C)cc2CC1)C(=O)N,Silodosin,3.6,1,
C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@H]3C[C@H](N(C)C3)C(=O)N4CC[C@@H](C4)NC(=O)CNC(=N)N,Tomopenem,1.7,0,
Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4c(F)cccc4Cl,Flucloxacillin,1.4,0,
CCOc1ccccc1OCCN[C@H](C)Cc2ccc(OC)c(c2)S(=O)(=O)N,Tamsulosin,6.8,1,
CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(cc(NC(=O)CNC(C)(C)C)c(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C,Tigecycline,48,1,
COc1cc(NS(=O)(=O)C)ccc1Nc2c3ccccc3nc4ccccc24,Amsacrine,4.7,1,
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O,Bortezomib,18,1,
C[C@@H]([C@@H](O)c1ccc(O)cc1)N2CCC(O)(CC2)c3ccccc3,Traxoprodil,3.7,1,
CCCCCc1cc(O)c2[C@@H]3C=C(C)CC[C@H]3C(C)(C)Oc2c1,"Tetrahydrocannabinol, D9-",33,1,
CCN(CC)CCNC(=O)c1ccc(NC(=O)C)cc1,Acecainide (N-acetylprocainamide),6.4,1,
c1(c(c(c(I)c(c1I)C(NC[C@@H](CO)O)=O)C(NC[C@@H](CO)O)=O)I)N(C[C@@H](COC)O)C(C)=O,Iopentol,2.04,0,
CCOc1ccc(NC(=O)C)cc1,Phenacetin,0.92,0,
c1(c(c(cc(c1O)Cl)Cl)OC)C(=O)NC[C@H]1N(CCC1)CC,Raclopride,14,1,
CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,GSK1322322,4.9,1,
CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5c(N)cccc5nc34)C2=O,Fluconazole,7,1,
C([C@H]1N(CCC1)C([C@@H](Cc1ccccc1)N)=O)(=O)N[C@H](C(N1[C@H](C(=O)NCC(=O)NCC(NCC(=O)NCC(=O)N[C@H](C(NCC(=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@H](C(N[C@H](C(N[C@@H](Cc2ccc(O)cc2)C(N[C@@H](CC(C)C)C(=O)O)=O)=O)CCC(O)=O)=O)CCC(O)=O)[C@H](CC)C)=O)CCC(O)=O)=O)CCC(O)=O)=O)Cc2ccccc2)=O)CC(O)=O)=O)CC(=O)N)=O)CCC1)=O)CCCNC(N)=N,BB 83698,0.42,0,
CCCCCCCN(CC)CCCC(O)c1ccc(NS(=O)(=O)C)cc1,Gadodiamide,7,1,
[Gd+3].COCCNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NCCOC)CC([O-])=O)CC([O-])=O,Gadoversetamide,1.7,0,
c12[C@@]3([C@@H](N(C)c1ccc(c2)OC(NC)=O)[N@@](C)CC3)C,Physostigmine,1,0,
c1(c2c(cccc2)[nH]c1)C[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC([C@@H](CSSC[C@@H](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)C(C)C)=O)C(N[C@@H]([C@@H](C)O)C(=O)N)=O)NC(=O)[C@@H](N)Cc1ccc2c(c1)cccc2)=O,Lanreotide,1.03,0,
N1(c2c(NC(c3c1cccc3)=O)cccn2)C(CN1CCN(C)CC1)=O,Pirenzepine,11.1,1,
N1C(\C(c2ccccc12)=C/c1[nH]c(cc1C)C)=O,Semaxanib,0.83,0,
c12c(c[nH]c1nc(N)[nH]c2=O)CCc1ccc(C(N[C@H](CCC(=O)O)C(=O)O)=O)cc1,Pemetrexed,1.85,0,
O1[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@@]5(C)[C@H]4[C@H](C[C@@]3([C@]2(C(CO)=O)OC1(C)C)C)O,Flunisolide,1.68,0,
[H]N(c1c(C)cccn1)S(c1ccc(C#Cc2ccc(c(c2)C(=O)O[H])O[H])cc1)(=O)=O,Susalimod,16,1,
COCCc1ccc(OCC(O)CNC(C)C)cc1,Metoprolol,3.6,1,
OC(CNCCNC(=O)N1CCOCC1)COc2ccc(O)cc2,Xamoterol,7.7,1,
c12CC(c3c(N(c2cccc1)C(=O)N)cccc3)O,Licarbazepine,9.8,1,
O1[C@@H](O[C@@H](c2ccccc2)C#N)[C@@H]([C@@H](O)[C@@H]([C@H]1CO[C@@H]1O[C@@H]([C@@H](O)[C@@H]([C@H]1O)O)CO)O)O,Amygdalin,1.23,0,
c1ccc2ccccc2c1OC[C@@H](CN1CCN(CC1)c1c(cccc1)OC)O,Naftopidil,3.3,1,
CCOc1ccccc1O[C@@H]([C@H]2CNCCO2)c3ccccc3,Reboxetine,10,1,
NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O,Ribostamycin,2.5,0,
CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,Melperone,3.9,1,
CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O,Alprostadil,1.9,0,
[H]O[C@]1(CC)CC(=O)OCC2=C1C=C1c3c(CN1C2=O)cc1cc(c(cc1n3)F)F,Diflomotecan,3.1,1,
N1[C@@H](C)CN(CC1)c1c(F)cc2c(c(cn(c2c1F)CC)C(O)=O)=O,Lomefloxacin,8.1,1,
CN(C)CCCN1c2ccccc2CCc3cc(O)ccc13,"Hydroxyimipramine, 2-",10,1,
NC1CCN(C1)c2c(F)cc3C(=O)C(=CN(C4CC4)c3c2Cl)C(=O)O,Clinafloxacin,5.4,1,
c12c([nH]cc1CCNC(C)=O)ccc(c2)OC,Melatonin,1.1,0,
CC(C)(C)C1(O)CC2OC(=O)CC23C(=O)OC4OC(=O)C(O)C134,Bilobalide,3.2,1,
CC(C)([C@H](C(=O)O)N)S,"Penicillamine, D-",3.04,1,
Oc1ccc2c(Oc3cc(O)ccc3C24OC(=O)c5ccccc45)c1,Fluorescein,1.6,0,
CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35,Morphine,2,0,
C1C[C@@H](N)[C@H](O[C@@H]1CNC)O[C@@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)N)O[C@@H]1[C@@H]([C@H]([C@](CO1)(O)C)NC)O)O,Micronomicin,2.1,0,
C[C@@H](O)[C@@H]1[C@H]2SC(=C(N2C1=O)C(=O)O)SCCOC(=O)N,Sch34343,0.8,0,
Cn1c(nc(=O)c(n1)O)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/c4csc(n4)N)SC2)C(=O)O,Ceftriaxone,7.6,1,
c12c(N(C(c3cc4cc(NC(Nc5cc6c([nH]c(c6)C(N6c7c(c8c([nH]cc8C)c(c7)O)[C@@H](C6)CCl)=O)cc5)=O)ccc4[nH]3)=O)C[C@H]2CCl)cc(O)c2c1c(c[nH]2)C,Bizelesin,1.6,0,
c1cc(ccc1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCc2cnc3c(n2)c(=O)nc([nH]3)N,Folic acid,2.6,0,
CCc1c(cc(c(c1CC(=O)N(CCOC)CCOC)C(=O)c2ccc(c(c2)OC)OCCN3CCOCC3)O)O,KW-2478,5.94,1,
CC[C@@H](c1cc(c(c(c1)OC)OC)OC)C(=O)N2CCCC[C@H]2C(=O)O[C@H](CCc3ccc(c(c3)OC)OC)c4cccc(c4)OCC(=O)NCCNC(=O)COc5cccc(c5)[C@@H](CCc6ccc(c(c6)OC)OC)OC(=O)[C@@H]7CCCCN7C(=O)[C@@H](CC)c8cc(c(c(c8)OC)OC)OC,Rimiducid,7.18,1,
O1[C@@H](O[C@@]23[C@@]4([C@@H]([C@@]5(C[C@@]2(C)O[C@@H]4O5)O)C3)COC(=O)c2ccccc2)[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O,Paeoniflorin,1.49,0,
CNC1(CCCCC1=O)c2ccccc2Cl,Ketamine,2.8,0,
[H]Oc1ccc2c(C[C@H](CCCCCCCCCS(CCCC(C(F)(F)F)(F)F)=O)C3[C@@H]2CC[C@@]2(C)[C@H]3CC[C@@H]2O[H])c1,Fulvestrant,16,1,
COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccccc3,Mebendazole,1.1,0,
CN(C)CCC=C1c2ccccc2CCc3ccccc13,Amitriptyline,17,1,
CO[C@]1(NC(=O)C2SC(=C(C(=O)N)C(=O)O)S2)[C@H]3SCC(=C(N3C1=O)C(=O)O)CSc4nnnn4C,Cefotetan,4.5,1,
[H]N([H])c1nc(C(C(N([H])[C@H]2C(N3C(=C(CN4C=CN5C4=CC=C[N-]5)CS[C@H]23)C(=O)O[H])=O)=O)=NOC)ns1,Cefozopran,1.7,0,
Nc1ccc(O)c(c1)C(=O)O,"Aminosalicylic acid, 5-",0.61,0,
CN(CCCN1CCc2cc(c(cc2CC1=O)OC)OC)CCc3ccc(c(c3)OC)OC,Zatebradine,2.8,0,
CN(C)CCCN1c2ccccc2Sc3ccccc13,Promazine,7.9,1,
O[C@H]1[C@@H](O[C@@H]([C@@H]([C@@H]1O)O)CO)n1c(=O)[nH]c(=O)c(c1)F,OGT719,4.21,1,
c1(nnc(s1)C)SCC=1CS[C@H]2N(C1C(O)=O)C([C@H]2NC(Cn1cc(c(c(c1)Cl)=O)Cl)=O)=O,Cefazedone,1.91,0,
c1cn(c(n1)[N+](=O)[O-])CC(=O)NCC(C(F)(F)F)O,,3.45,1,
FC1=CNC(=O)NC1=O,"Fluorouracil, 5-",0.12,0,
NCCCCCC(=O)O,"Aminohexanoic acid, 6-",4.9,1,
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSc3nc(C)c(CC(=O)O)s3)\c4csc(N)n4,Cefodizime,4.2,1,
C[C@@](O)(\C=C\[C@H]1CC=CC(=O)O1)[C@@H](C[C@@H](O)\C=C/C=C\C=C\CO)OP(=O)(O)O,Fostriecin,1.5,0,
C1(C2=C([C@H](C[C@]1([C@H]([C@H]1[C@](C(=O)[C@@H]2OC)([C@H](C[C@@H]2[C@]1(CO2)OC(=O)C)OC)C)OC(=O)c1ccccc1)O)OC(=O)[C@@H]([C@H](c1ccccc1)NC(=O)OC(C)(C)C)O)C)(C)C,Cabazitaxel,74.5,1,
[H]N(CC(N1CCC[C@@H]1C#N)=O)C12C[C@@H]3C[C@H](C1)CC(C3)(C2)O[H],Vildagliptin,1.67,0,
CCOC(=O)C1(CCN(CC1)CCC(c2ccccc2)O)c3ccccc3,Phenoperidine,3.22,1,
CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,Finasteride,6,1,
NCC1(CC(=O)O)CCCCC1,Gabapentin,5.3,1,
CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,Methotrexate,3.9,1,
CO[C@]1(NC(=O)[C@H](C(=O)O)c2ccc(O)cc2)[C@H]3OCC(=C(N3C1=O)C(=O)O)CSc4nnnn4C,Moxalactam,2.9,0,
[C@@H]12N(C(=O)[C@H](Cc3c4c([nH]c3)cccc4)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CCSSC[C@H](NC1=O)C(=O)N)CCCNC(=N)N)CC(=O)O)CCC2,Batifiban,2.12,0,
c12c(cc(C#Cc3ccc(C(OCC)=O)cn3)cc1)C(CCS2)(C)C,Tazarotene,6.22,1,
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F,Gemcitabine,1,0,
c1ccc2c(c1)/C(=C/CCN3CCN(CC3)CCO)/c4cc(ccc4S2)C(F)(F)F,Flupentixol,34.2,1,
CN(=O)(C)CCCN1c2ccccc2CCc3ccccc13,Imipramine N-oxide,1.8,0,
n1(Cc2ccc(cc2)F)c(N2CCC(CC2)N(C)c2nccc([nH]2)=O)nc2c1cccc2,Mizolastine,9.6,1,
C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4,Artesunate,0.22,0,
CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2,Chlorpheniramine,22,1,
O=S(=O)(N1CCCNCC1)c2cccc3cnccc23,Fasudil,0.44,0,
CC(C)c1cccc(C(C)C)c1O,Propofol,3.2,1,
OC(CCN1CCCCC1)(C2CC3CC2C=C3)c4ccccc4,Biperiden,24,1,
CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)N(=O)=O)C(=O)OC)C,Nitrendipine,8.2,1,
c1cc(ccc1Cl)SC(P(O)(O)=O)P(O)(O)=O,Tiludronate,7.7,1,
CN1CCN(CC1)C(=O)OC2N(C(=O)c3nccnc23)c4ccc(Cl)cn4,Zopiclone,5.2,1,
CO\N=C(\C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C([O-])=O)C[n+]1ccc(N)n1CCO)c1csc(n1)N,Cefoselis,2.9,0,
Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12,Midazolam,3.1,1,
C[C@@H]1CC(=O)NN=C1c2ccc(NN=C(C#N)C#N)cc2,Levosimendan,1.1,0,
CCCC[C@@H]1CC(=O)[C@]2(O)O[C@@H]3[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@H]3O[C@@H]2O1,Trospectomycin,11,1,
CN1C(=O)C(O)N=C(c2ccccc2Cl)c3cc(Cl)ccc13,Lormetazepam,4.9,1,
CC1=C(CCN2CCC(CC2)=C(c2ccc(cc2)F)c2ccc(cc2)F)C(N2C=CSC2=N1)=O,Ritanserin,40,1,
CN1N=Nc2c(ncn2C1=O)C(=O)N,Temozolomide,1.5,0,
C(CC(C)(N)C)(N[C@H](C(N[C@@H](Cc1c[nH]cn1)C(N[C@H]([C@H]([C@@H](O)CC(C)C)O)CC1CCCCC1)=O)=O)Cc1ccc(cc1)OC)=O,Enalkiren,1.72,0,
NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N2CCC(CC2)N3Cc4ccccc4NC3=O)C(=O)N5CCN(CC5)c6ccncc6,Olcegepant,2.5,0,
O=N(=O)O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)ON(=O)=O,Isosorbide Dinitrate,1.7,0,
CC([N@+]1([C@@H]2C[C@@H](C[C@@H]1CC2)OC(=O)[C@@H](C3CCCC3)c4ccccc4)C)C,Ciclotropium,3.3,1,
